You are currently viewing Robert Milnes, CEO of Fertility Focus that produces OvuSense

Robert Milnes, CEO of Fertility Focus that produces OvuSense

We came to Panpathic during a relaunch of our product, via some people we were working with on a crowd-funding/investment project.

At the time we were looking for some angel investors to get involved and hiring a PR company was not something we had considered. However, the crowd-funding agency outsourced all of the PR side of the campaign and that’s how we found ourselves working with Chantal from Panpathic.

We didn’t consciously make the decision to engage a PR company and, to be honest, I was probably a bit hesitant about it because of my experience with PR in the past.

Up until that point, every experience of working with PR companies had been very different from what we discovered when we started working with Panpathic.

As soon as we engaged with them, there was a real buzz created around our product and our company and we got quite a lot of press and media coverage very quickly.

Panpathic did really well in creating news-worthy articles for OvuSense and I believe this is one of the reasons why there was a spike in sales very early on.

In the past, one of the problems we encountered when using PR companies was having to rewrite drafts of copy over and over again. We have a very specific product; it has a 99 per cent success rate and has helped women who have been told by their doctors that they are not ovulating, many of whom have being trying to get pregnant for a very long time without success.

We knew there were some very positive stories behind our product but up until then I had found PR to be a very broad brush and we weren’t really making the connection about what it was we wanted to convey to the media. I wasn’t really convinced it could work for us, but we quickly established a very good, strong, working relationship with Panpathic. Right from the start, they seemed to get where we were coming from and they understood us and our product and what we were trying to achieve. We were definitely on the same page.

Panpathic took no time in getting to the bottom of what we needed, and as a result of that we didn’t have to do very much re-drafting for articles that were being sent out to the media, which made the whole process quite smooth for us. That really was very different to our past dealings with public relations and it is fair to say that using a PR company on that occasion turned out to be a big success for us.

During the six-week campaign when we were working together, we had 7 pieces of print and digital coverage, reaching more than 189 million people with an advertising equivalent value of more than £69,000.

This included articles in the Mail online, Chat magazine, Sloan and Positive Health, all reaching our target market, placing us exactly where we needed to be.

The Mailonline led to so many sales that we had our best month ever which in turn led to our best quarter ever.

Our relationship with Panpathic was good. I know PR has gone through some massive changes with social media making a big difference for companies who want to get their information out there. But all I can say is it worked for us and helped us to achieve what we wanted to achieve for our re-launch.

Today, we still use a PR company in America for our US arm of OvuSense, which is very different and although we don’t use a PR firm in the UK at the moment, I would definitely recommend Panpathic to any companies out there who are trying to launch or relaunch their brands. We were very pleased with the results we got from Panpathic and they were very professional and easy to work with.